Cargando…
Immune dysregulation and system pathology in COVID-19
The coronavirus disease 19 (COVID-19) caused by the novel coronavirus known as SARS-CoV-2 has caused a global public health crisis. As of 7 January 2021, 87,640,402 confirmed cases and 1,891,692 mortalities have been reported worldwide. Studies focusing on the epidemiological and clinical characteri...
Autores principales: | Jamal, Muhammad, Bangash, Hina Iqbal, Habiba, Maria, Lei, Yufei, Xie, Tian, Sun, Jiaxing, Wei, Zimeng, Hong, Zixi, Shao, Liang, Zhang, Qiuping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7993139/ https://www.ncbi.nlm.nih.gov/pubmed/33757410 http://dx.doi.org/10.1080/21505594.2021.1898790 |
Ejemplares similares
-
Targeting chemokines for acute lymphoblastic leukemia therapy
por: Hong, Zixi, et al.
Publicado: (2021) -
Clinical Characteristics and Immune Injury Mechanisms in 71 Patients with COVID-19
por: Wu, Yingjie, et al.
Publicado: (2020) -
CCR9 overexpression promotes T-ALL progression by enhancing cholesterol biosynthesis
por: Jamal, Muhammad, et al.
Publicado: (2023) -
Recent Progress on Circular RNA Research in Acute Myeloid Leukemia
por: Jamal, Muhammad, et al.
Publicado: (2019) -
CLEC3B as a potential diagnostic and prognostic biomarker in lung cancer and association with the immune microenvironment
por: Sun, Jiaxing, et al.
Publicado: (2020)